Evidence map›Paper›PMID 40980262›Full record

ArticlePhysics and imaging in radiation oncology2025

Quantifying movement of optical structures during radiotherapy treatment for tumors near the orbita.

Femke Vaassen, David Hofstede, Nikolina Birimac, Inge Compter, Marlies Granzier, Wouter van Elmpt, Catharina M L Zegers, Daniëlle B P Eekers

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Femke VaassenDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
David HofstedeDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Nikolina BirimacDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Inge CompterDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Marlies GranzierDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Wouter van ElmptDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Catharina M L ZegersDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Daniëlle B P EekersDepartment of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Movement of optical structures during radiotherapy for tumors near the orbita might affect the amount of radiation given and consequently the risk for side effects. The aim of this study was therefore to quantify motion of optical structures during radiotherapy. Materials and methods: Twenty brain tumor patients were retrospectively included, with planning computed tomography (CT)-scan (pCT) and five repeat-CT-scans (reCTs) without gazing instructions. Six optical structures were delineated bilaterally: lens, cornea, retina, lacrimal glands, macula, and optic nerves (ON). The ON was split in three subregions. The dice similarity coefficient (DSC), absolute distance (AD), and difference in 3D midpoint (ΔMP) were calculated between pCT and reCT. Planning risk volume (PRV)-margins and isotropic expansions to cover 95 % volume for 90 % patients were calculated. A dose-volume proof-of-principle was performed for a neurological and nasopharyngeal tumor. Results: Highest median ΔMP was found for the cornea: 1.9 mm. For ON subregions, highest median and 95th-percentile ΔMP was found for proximal intra-orbital ON: 1.3 mm and 3.1 mm. ON showed highest median AD: 3.0 mm (negative Z-direction). Open eyelid status resulted in statistically significant lower DSC for ON, intra-cranial ON, and proximal intra-orbital ON, and higher ΔMP for proximal intra-orbital ON. 1-4 mm isotropic expansions were needed for separate structures, dependent on typical movement range. Higher dose-differences were found for the neurological than the nasopharyngeal plan. Conclusions: The observed movement of optical structures indicated that a PRV-margin should be considered in clinical practice. Asking the patient to close their eyes during the treatment could decrease the movement.

Indexed as

Optical movementOrgans-at-riskPRV marginsRadiation therapy

Identifiers

PMID40980262
PMCPMC12446562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.